3 replies to this topic

[YOLF]

Sounds promising, and has weight loss properties to boot!

 

http://news.usc.edu/...1cff38-86592401

[albedo]

Interesting indeed.

 

With more pressure on regulatory bodies to consider sarcopenia as an indication (e.g. see here and here) there seems to be a blossoming of opportunities for research in this area and drug development. I was in a meeting last year were I recollect a scientist mentioning sarcopenia has been granted a disease code which is generating several trials on the market. Hopefully (for me at least) this will intersect with SENS where hopefully the related controversy will calm down and progresses are indeed being done (e.g. see here and last SENS 2016 Annual Report)

 

The work at USC let me think about the work at EPFL on a different molecule and path (e.g. see here and here) but similar general scopes.

 

PS Sorry Yolf, I do not know where you can get MOTS-c.

 

edit: the PS

 

 

 

 

Edited by albedo, 07 July 2017 - 10:44 AM.

[aconita]

http://www.adipogen....026/mots-c.html

 

or have it custom made by Genscript (H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH).

 

But if one isn't bed ridden hitting the gym is likely a smarter option.

[YOLF]

Not going to use it, just want to know where to tell people to get it so I can help the research along. It's the best candidate I've seen in a while.